Does Warfarin Interact with Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa?
Warfarin and Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa have a moderate drug interaction according to U.S. FDA drug labeling data. Methylene blue inhibits CYP2C9 metabolism. Warfarin has narrow therapeutic index; clinical relevance unknown but concurrent use requires caution. The mechanism involves cyp2c9 inhibition by methylene blue. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Warfarin and Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa occurs because cyp2c9 inhibition by methylene blue. Clinically, this means methylene blue inhibits cyp2c9 metabolism. warfarin has narrow therapeutic index; clinical relevance unknown but concurrent use requires caution. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Warfarin and your doctor is considering prescribing Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider